Key facts
- Notable investors include Takeda Ventures, LINK-J, Whiz Partners.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Axcelead
- ·The full record, as it builds
Funding rounds
No funding rounds for Axcelead are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Axcelead
Provider of drug discovery services intended to bridge the foundational sciences to clinical developments. The company's services aim to bridge basic and applied clinical research from exploratory research to optimizing candidate compounds, enabling clients and the healthcare sector to access drug-discovery expertise and technologies
- Sector
- Healthcare
- HQ
- Fujisawa, Japan
- Founded
- 2017
- Employees
- 70
- Website
- axcelead.com/
- Ownership
- Privately Held (backing)
Axcelead doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Axcelead shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Axcelead in its N-PORT filings yet. We sweep new filings monthly.